Radiofrequency Echographic Multi Spectrometry

Aurora Spine Corporation Announces Initial Implantation of the World’s First Bone Density Matched DEXA-C Cervical Interbody Fusion Device

Retrieved on: 
Thursday, March 3, 2022

Trent Northcutt, CEO and President at Aurora Spine said, "It's a significant milestone for Aurora to announce the completion of the worlds first surgical implantations of the DEXA-C patient-bone-density matched interbody devices.

Key Points: 
  • Trent Northcutt, CEO and President at Aurora Spine said, "It's a significant milestone for Aurora to announce the completion of the worlds first surgical implantations of the DEXA-C patient-bone-density matched interbody devices.
  • Dr. Sebastian Koga, Neurosurgeon at Koga Neurosurgery in Covington, Louisiana said, "The DEXA-C implant from Aurora Spine ushers in a new era of personalized spine surgery.
  • This will expand access to spine surgery for older patients who were previously excluded by poor bone quality."
  • Aurora Spine has developed the DEXA family of implants which mimic the natural bone of patients with osteopenia and osteoporosis.

Aurora Spine Corporation Announces Co-Marketing Agreement for its DEXA Platform with Echolight Medical

Retrieved on: 
Thursday, February 24, 2022

Aurora is developing and manufacturing DEXA Technology-based Spinal Implants, and Echolight is engaged in the business of bone health assessment without the use of ionizing radiation.

Key Points: 
  • Aurora is developing and manufacturing DEXA Technology-based Spinal Implants, and Echolight is engaged in the business of bone health assessment without the use of ionizing radiation.
  • The two companies agreed to promote each other's products as part of the Aurora DEXA Platform to their respective customers and prospects.
  • Trent Northcutt, CEO and President at Aurora Spine said, "Aurora looks forward to working with Echolight and to offer comprehensive bone scanning capabilities with Auroras patient-matched DEXA Platform family of spinal implants.
  • Doug Tefft, President of Echolight stated "We are pleased to contribute to Auroras innovative DEXA Platform.

International association honors doctors using REMS technology

Retrieved on: 
Wednesday, January 20, 2021

SEATTLE, Jan. 20, 2021 /PRNewswire/ -- Echolight Medical is honored that a group of esteemed doctors using itsREMS technology has been granted the Young Investigator Award by the International Society forClinical Densitometry (ISCD) in May 2020.

Key Points: 
  • SEATTLE, Jan. 20, 2021 /PRNewswire/ -- Echolight Medical is honored that a group of esteemed doctors using itsREMS technology has been granted the Young Investigator Award by the International Society forClinical Densitometry (ISCD) in May 2020.
  • Tomai Pitinca, C. Caffarelli, S. Gonnelli), patients who underwent bothexaminations showed that REMS measurements in the lumbar spine were lower than DXA measurements in the same location, which indicates that REMS technology can be a highlyreliable method of examination in the evaluation of BMD and fracture risk in patients with spinal artifacts.
  • Echolight's flagship REMS device, the EchoS , is the first clinically available method for the directnon-ionizing measurement of BMD at the axial sites, which provides significantly quicker results that lead to more effective early-stage diagnosis.
  • About EchoS: Portable, diagnostic, radiation-free bone health densitometer - a safe, accurate, andcost-effective medical device elevating bone health awareness and treatment to mainstream medical care.